SHY THERAPEUTICS, LLC — Federal Contracts, Awards & Government Contractor Profile

About SHY THERAPEUTICS, LLC

SHY Therapeutics is a biotechnology company focused on the discovery and early clinical development of small molecule therapeutics targeting ATPases and GTPases for critical underserved diseases. The company leverages a novel compound portfolio derived from machine learning and structure-activity relationship analyses.

Discovery and early clinical development of small molecule therapeuticsTargeting ATPases and GTPases with high specificity and wide therapeutic windowsIn vitro and in vivo experimentation in-houseCollaboration with partners for pharmacokinetic studies, medicinal chemistry, and compound synthesisUse of machine learning and in-silico libraries for compound development

Is this your company?

Claim SHY THERAPEUTICS, LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim SHY THERAPEUTICS, LLC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.